Tandem Diabetes Care
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its o...
Latest News
19 hours ago · seekingalpha.com
Tandem: Wait Out The 2027 Transition Before Chasing The TurnaroundI maintain a Hold rating on Tandem Diabetes Care: near-term underperformance offsets significant potential upside after 2027. TNDM's record Q3 revenue rose 13.8%, but international one-offs masked 9% U.S. growth; unchanged FY26 guidance suggests underlying U.S. weakness. PayGo doubles four-year patient revenue to roughly $17,000, but delayed breakeven, attrition risk, and slow pharmacy adoption temper the thesis.
3 days ago · benzinga.com
Tandem Mobi Becomes Only Insulin Pump Offering Both Tubed and Tubeless Wear OptionsGlobal insulin delivery and diabetes technology company Tandem Diabetes Care, Inc. (NASDAQ:TNDM) secured U.S. Food and Drug Administration clearance for Tandem Mobi as the world's first and only tubeless automated insulin delivery system offering up to seven days of wear for users.
3 days ago · businesswire.com
Tandem Mobi Now FDA Cleared as World's First and Only Tubeless AID System with up to Seven Days of WearSAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of Tandem Mobi for use as the world's first and only tubeless automated insulin delivery system with up to 7 days of wear.1 A new Tandem Mobi tubeless cartridge and infusion set converts the current Tandem Mobi pump into a tubeless device that can help simplify diabetes management with less frequent si.
4 days ago · businesswire.com
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin PumpSAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of Health Canada approval of a license amendment for the t:slim X2™ insulin pump with Control-IQ+™ automated insulin delivery (AID) technology. This approval adds compatibility with Abbott's FreeStyle Libre® 3 Plus Sensor and expands the t:slim X2 system's indications for use to people with type 1 diabetes during pregnancy and to adults with.
10 days ago · marketbeat.com
What Tandem Diabetes Care (TNDM) Said on Its Q3 Earnings CallTandem Diabetes Care NASDAQ: TNDM reported 14% revenue growth in the third quarter of 2026, as higher pump shipments, pharmacy pricing and international sales helped lift gross margin. The company also announced a CEO transition and signaled that a slower-than-expected shift to pharmacy distribution could weigh on revenue growth next year.
11 days ago · seekingalpha.com
Tandem Diabetes Care, Inc. (TNDM) Q3 2026 Earnings Call TranscriptTandem Diabetes Care, Inc. (TNDM) Q3 2026 Earnings Call Transcript
11 days ago · zacks.com
Tandem Diabetes Care (TNDM) Reports Q3 Earnings: What Key Metrics Have to SayAlthough the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
11 days ago · zacks.com
Tandem Diabetes Care, Inc. (TNDM) Reports Q3 Loss, Beats Revenue EstimatesTandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.31 per share a year ago.
17 days ago · businesswire.com
Tandem Diabetes Care Announces Upcoming Conference PresentationsSAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:Jefferies Global Healthcare Conference on Thursday, November 19, 2026 at 8:00am Greenwich Mean Time (3:00am Eastern Time, 12:00am Pacific Time), andPiper Sandler 38th Annual Healthcare Conference on Thursday, December 3, 2026 at 9:00am Eastern Time (6:00am Pacific Time.
19 days ago · zacks.com
Tandem Diabetes Care, Inc. (TNDM) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseTandem Diabetes Care (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove TNDM